人乳头瘤病毒疫苗在宫颈癌筛查项目中的效果:队列研究
在意大利费拉拉省2011-2018年宫颈筛查项目中,对1986-1993年出生且符合补种条件的7785名女性进行回顾性队列分析。接种至少一剂HPV疫苗者宫颈细胞学异常风险显著降低(调整OR 0.52,95%CI 0.34-0.79)。补种HPV疫苗使细胞学异常风险几乎减半。
要点
- 接种至少一剂HPV疫苗与宫颈细胞学异常风险降低相关(调整OR 0.52,95%CI 0.34-0.79)。
- 单剂接种、二价和四价疫苗及设置缓冲期后均观察到相似结果。
- 在组织性宫颈筛查项目中,补种HPV疫苗使细胞学异常风险几乎减半。
核心结论
- 在意大利组织性宫颈筛查项目背景下,补种HPV疫苗使细胞学异常风险几乎减半。
研究设计与样本
- 回顾性队列研究,使用行政健康数据,纳入意大利费拉拉省1986-1993年出生且参与2011-2018年组织性宫颈筛查项目的女性居民,这些女性符合补种队列的HPV疫苗接种条件。
- 样本共7785名女性,平均年龄27.5岁(SD 2.3)。
主要发现
- 391名(5.0%)接种至少一剂疫苗,893名(11.5%)有异常细胞学。
- 接种至少一剂疫苗的女性发生异常细胞学的可能性显著更低(调整OR 0.52;95%CI 0.34-0.79)。
- 单剂接种、二价和四价疫苗以及应用缓冲期(排除首剂后1个月、6个月和1年内的细胞学结局)后均观察到相似结果。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the effectiveness of an HPV vaccination programme in reducing the risk of cervical abnormalities identified at subsequent screening. DESIGN: Retrospective cohort study using administrative health data. SETTING: General population of Ferrara Province, Italy. POPULATION: Female residents born in 1986-1993 and participating in the organized cervical screening programme in 2011-2018, who were eligible for HPV vaccination in catch-up cohorts. METHODS: Logistic regression to evaluate the potential association between abnormal cervical cytology and one, two, three or at least one dose of HPV vaccine. MAIN OUTCOME MEASURES: Cervical abnormalities, as predicted by low-grade or high-grade cytology, by number of vaccine doses, stratified by age. RESULTS: The sample consisted of 7785 women (mean age 27.5 years, SD 2.3). Overall, 391 (5.0%) were vaccinated with ≥1 dose and 893 (11.5%) had abnormal cytology. Women receiving at least one vaccine dose were significantly less likely to have an abnormal cytology (adjusted odds ratio 0.52; 95% confidence interval 0.34-0.79). Similar results were observed for women receiving a single dose, for both bivalent and quadrivalent vaccines, and applying buffer periods (excluding cytological outcomes within 1 month, 6 months and 1 year of the first dose). CONCLUSIONS: In the context of an organised cervical screening programme in Italy, catch-up HPV vaccination almost halved the risk of cytological abnormalities. TWEETABLE ABSTRACT: Among Ferrara women, vaccination against human papillomavirus halved the risk of screening cervical abnormalities.
引用
- Acuti Martellucci C, Nomura S, Yoneoka D, et al. Human papillomavirus vaccine effectiveness within a cervical cancer screening programme: cohort study. BJOG. 2020. PMID: 32779381. doi:10.1111/1471-0528.16429
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。